Prestige Consumer Healthcare's Subsidiary Insight Pharmaceuticals Issues Voluntary Nationwide Recall Of TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder Due To The Presence Of Benzene
Portfolio Pulse from Benzinga Newsdesk
Insight Pharmaceuticals, a subsidiary of Prestige Consumer Healthcare, has issued a voluntary nationwide recall of TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder. The recall is due to the detection of benzene, a known carcinogen, in the product. This recall may affect the company's reputation and could lead to financial implications due to potential returns, legal action, or regulatory penalties.
November 24, 2023 | 1:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Prestige Consumer Healthcare's subsidiary has recalled a product due to benzene contamination. This could negatively impact PBH's stock due to potential financial costs and damage to brand reputation.
The recall of a product due to a health hazard such as benzene can lead to significant costs associated with the recall process, potential lawsuits, and regulatory fines. Additionally, the negative publicity can harm the brand's reputation, potentially affecting sales of other products. These factors are likely to create downward pressure on PBH's stock price in the short term.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90